Pharmacy evidence record · researched 2026-08-20

PQ Pharmacy

PQ Pharmacy, LLC

5 citations5 action records4 explicit unknowns

Compounded with

Semaglutide

FDA inspection/warning records identify semaglutide products.

Tirzepatide

FDA's April 2025 Form 483 identifies tirzepatide 10 mg/mL and 20 mg/mL products.

Product evidence does not establish current availability.

Locations in the source record

  • 15215 Technology Drive, Brooksville, FL 34604

Services named by sources

  • Historical 503B sterile compounding
  • Outsourcing-facility bulk sterile products

Regulatory compliance

503 pathway evidence

A pathway label describes which federal rules apply — it is not a quality claim.

Section 503A

Source-backed negative

not supported

Section 503B

Not conclusively established

The 2025 warning states that PQ registered under section 503B; the agent did not find PQ in the FDA current weekly list dated 2026-08-18, so current registration is not asserted.

Telehealth providers

No provider relationship is verified in the bound sources.

Clinic Scout links a provider only when an explicit source names the relationship.

Browse provider records

Regulatory history

Actions stay dated and bounded.

FDA warning-letter/Form 483/current-503B and Florida license/action sources were checked. Multiple FDA actions were verified; Florida showed no discipline.

U.S. Food and Drug Administration · 2022-08-12

Form FDA 483

issued

U.S. Food and Drug Administration · 2022-10-27

Amended Form FDA 483

issued

U.S. Food and Drug Administration · 2025-04-04

Form FDA 483

FDA observations addressed sterile production practices and listed semaglutide and tirzepatide products.

Status not stated

U.S. Food and Drug Administration · 2025-08-08

Form FDA 483

issued

U.S. Food and Drug Administration · 2025-10-10

Warning Letter

FDA stated that products failed section 503B conditions and described insanitary conditions, CGMP violations, unapproved drugs and misbranding.

Status not stated

What remains unverified

No Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.

What this record verifies for you

7 evidence dimensions carry dated, source-backed verification.

Each line traces to a citation in the source list below — read the exact captured wording before relying on it.

No superiority claim is made for review volume, ratings, or patient sentiment.

Sources and exact captured wording

  1. first_party · accessed 2026-08-20
    Located in Brooksville, Florida, PQ Pharmacy is a USP 800 and CGMP compliant FDA-Registered 503B Outsourcing Facility.
  2. fda · accessed 2026-08-20
    You registered your facility with the U.S. Food and Drug Administration (FDA) as an outsourcing facility under section 503B ... drug products you produced failed to meet the conditions of section 503B
  3. fda · accessed 2026-08-20
    Semaglutide 2.5mg/mL (2mL and 4mL vials) ... Tirzepatide 10mg/mL (1mL and 3mL vials) ... Tirzepatide 20mg/mL (3mL vials)
  4. state_board · accessed 2026-08-20
    PQ PHARMACY, License Number: PH33659, License Status: Clear/, Qualifications: Special Sterile Compounding Outsourcing Facility ... Discipline on File: No
  5. fda · accessed 2026-08-20
    Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.

Questions readers ask

Is PQ Pharmacy legit?

GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 5 dated first-party or regulator citation(s), 5 regulatory/action record(s), and 4 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.

Still have questions? Read the research library or email us at [email protected].